BioMarin to Participate in Three Upcoming Investor Conferences

Rhea-AI Summary

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will be presenting at three investor conferences in September: Citi's 18th Annual BioPharma Conference on September 6, Morgan Stanley 21st Annual Global Healthcare Conference on September 11, and Baird's 2023 Global Healthcare Conference on September 12. The presentations will be available via live audio webcast on the company's website, and an archived version will be accessible for a limited time after the conferences.

• Citi's 18th Annual BioPharma Conference on September 6 at 3:30pm ET
• Morgan Stanley 21st Annual Global Healthcare Conference on September 11 at 10:00am ET
• Baird's 2023 Global Healthcare Conference on September 12 at 1:25pm ET

SAN RAFAEL, Calif., Sept. 5, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that company management will present at three upcoming investor conferences in September. 

An audio webcast of the presentations will be available live. You can access the webcasts at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin
Founded in 1997, BioMarin is a global biotechnology Company dedicated to transforming lives through genetic discovery. The Company develops and commercializes targeted therapies that address the root cause of the genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The Company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com.

Contacts:
Investors	Media
Traci McCarty	Marni Kottle
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(650) 374-2803

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-three-upcoming-investor-conferences-301917400.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

What conferences will BioMarin Pharmaceutical be presenting at in September?

BioMarin Pharmaceutical will be presenting at Citi's 18th Annual BioPharma Conference, Morgan Stanley 21st Annual Global Healthcare Conference, and Baird's 2023 Global Healthcare Conference.

What is the date and time of the Citi's 18th Annual BioPharma Conference presentation?

The presentation at Citi's 18th Annual BioPharma Conference will take place on September 6 at 3:30pm ET.

What is the date and time of the Morgan Stanley 21st Annual Global Healthcare Conference presentation?

The presentation at Morgan Stanley 21st Annual Global Healthcare Conference will take place on September 11 at 10:00am ET.

What is the date and time of the Baird's 2023 Global Healthcare Conference presentation?

The presentation at Baird's 2023 Global Healthcare Conference will take place on September 12 at 1:25pm ET.

Where can I access the webcasts of the presentations?

The webcasts of the presentations can be accessed at https://investors.biomarin.com/.

Will there be an archived version of the presentations available?

Yes, an archived version of the presentations will be available through BioMarin Pharmaceutical's website for a limited time after the conferences.